Henry Schein, Inc. (HSIC) has recently completed the acquisition of orthopedic player TriMed for an undisclosed financial term. Integration of TriMed’s business will help the company to provide a wider range of surgical solutions to the existing Integrated Delivery Networks and Ambulatory Surgery Center customers. This will strengthen HSIC’s long-standing relationship with them.Headquartered in Santa Clarita, CA, TriMed is a global developer of solutions for the orthopedic treatment of lower extremities (fo ...

Henry Schein to Maximize Viome's Reach Among Dental and Medical Practices With Patient-Centric and Preventive Models of Care BELLEVUE, Wash., April 2, 2024 /PRNewswire/ -- Viome, a leading innovator of health technology and personalized health solutions, is partnering with Henry Schein to provide better access to Viome's Oral Health Pro™ With CancerDetect™.* Viome's laboratory-developed test* helps detect early biomarkers of oral and throat cancers, enhancing practitioners' ability to effectively harness th ...

Henry Schein has been recognized since 2012 and is one of only two honorees in the Healthcare Products industry. (Graphic: Business Wire)Henry Schein has been recognized since 2012 and is one of only two honorees in the Healthcare Products industry. (Graphic: Business Wire)MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, has received the 2024 World’s Most Ethical Companies® recognition ...

ZHENRY SCHEIN® Q4 2023 Earnings Conference Call Financial Results & Outlook | --- | --- | |------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Objective | Update | | | • Signed TriMed acquisition to ent ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) Commission file number 0-27078 HENRY SCHEIN, INC. (Exact name of registrant as specified in its charter) Delaware 11-3136595 incorporation or organization) (State or other jurisdiction of (I.R.S. Employer Identification No.) 135 Duryea Road Melville, New York (Address of principal executive offices) 11747 (Zip Code) (631) 843-5500 (Registrant's telephone number, including area code) Securities registered pursuant to ...

For the quarter ended December 2023, Henry Schein (HSIC) reported revenue of $3.02 billion, down 10.5% over the same period last year. EPS came in at $0.66, compared to $1.21 in the year-ago quarter.The reported revenue represents a surprise of -1.83% over the Zacks Consensus Estimate of $3.07 billion. With the consensus EPS estimate being $0.70, the EPS surprise was -5.71%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine ...

Henry Schein, Inc. (HSIC) registered adjusted earnings per share (EPS) of 66 cents in the fourth quarter of 2023, down 51.1% from the year-ago period’s adjusted EPS. The metric also lagged the Zacks Consensus Estimate by 7%.For the full year, adjusted earnings were $4.50 per share, down 16.4% from the year-ago period’s levels and also missed the Zacks Consensus Estimate by 1.3%.Revenues in DetailHenry Schein reported net sales of $3.02 billion in the fourth quarter, down 10.5% year over year. The metric lag ...

Henry Schein (HSIC) came out with quarterly earnings of $0.66 per share, missing the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $1.21 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -5.71%. A quarter ago, it was expected that this health care products maker would post earnings of $1.32 per share when it actually produced earnings of $1.32, delivering no surprise.Over the last four quarters, the c ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter and full year ended December 30, 2023. “We are pleased with our performance in the fourth quarter and for the full year 2023, which was in line with our expectations and reflects a solid recovery from last year’s cybersecurity incident,” said Stanley M. Bergman, Chairman of the Bo ...

Financial Performance - Fourth quarter total net sales were $3.0 billion, a decrease of 10.5% compared to Q4 2022, with an internal sales decrease of 12.0%[8]. - For full-year 2023, total net sales were $12.3 billion, a decrease of 2.4% compared to 2022, with an internal sales decrease of 4.4%[10]. - Fourth quarter sales in Global Dental were $1.8 billion, down 10.9%, while Global Medical sales were $1.0 billion, down 17.0%[7]. - Total Global sales for Q4 2023 decreased by 12.0% to $3,017 million compared to Q4 2022[39]. - Total Health Care Distribution sales for Q4 2023 decreased by 13.1% to $2,805 million compared to Q4 2022[39]. - North America Total Dental sales for Q4 2023 decreased by 12.1% to $1,053 million compared to Q4 2022[39]. - Full Year 2023 Total Global sales decreased by 2.4% to $12,339 million compared to Full Year 2022[42]. - Full Year 2023 Total Health Care Distribution sales decreased by 3.3% to $11,533 million compared to Full Year 2022[42]. - Full Year 2023 Technology and Value-Added Services sales increased by 11.4% to $806 million compared to Full Year 2022[42]. Earnings and Income - Fourth quarter GAAP diluted EPS was $0.13, while non-GAAP diluted EPS was $0.66, reflecting an estimated impact of $0.70 to $0.75 per diluted share from the cybersecurity incident[5][9]. - GAAP net income for 2023 was $416 million, or $3.16 per diluted share, down from $538 million, or $3.91 per diluted share in 2022[13]. - Net income attributable to Henry Schein, Inc. for Q4 2023 was $18 million, compared to $47 million in Q4 2022, a decrease of 61.7%[31]. - Basic earnings per share for Q4 2023 were $0.13, down from $0.35 in Q4 2022, a decline of 62.9%[31]. - Non-GAAP net income attributable to Henry Schein, Inc. for Full Year 2023 was $593 million, a decrease of 20.0% compared to Full Year 2022[45]. - Net income attributable to Henry Schein, Inc. for Q4 2023 was $18 million, a decrease from $47 million in Q4 2022, with full-year net income at $416 million compared to $538 million in 2022[51]. Cash Flow and Investments - Cash and cash equivalents at the end of Q4 2023 were $171 million, up from $117 million at the end of Q4 2022[36]. - The company reported a net cash used in investing activities of $327 million for Q4 2023, compared to $65 million in Q4 2022[36]. - The company invested $287 million in acquisitions during Q4 2023 and $955 million for the full year[12]. Debt and Liabilities - Long-term debt increased to $1,937 million as of December 30, 2023, from $1,040 million as of December 31, 2022, an increase of 86.2%[34]. - Total current liabilities rose to $2,683 million as of December 30, 2023, compared to $2,224 million as of December 31, 2022, an increase of 20.6%[34]. Future Outlook - The company expects 2024 non-GAAP diluted EPS to be between $5.00 and $5.16, reflecting growth of 11% to 15% compared to 2023[18]. - 2024 sales growth is anticipated to be approximately 8% to 12% over 2023, driven by merchandise sales recovery and acquisitions[18]. - Adjusted EBITDA for full-year 2024 is expected to increase by more than 15%[18]. Operational Metrics - Gross profit for Q4 2023 was $925 million, down from $999 million in Q4 2022, reflecting a gross margin of 30.7%[31]. - Operating income decreased to $39 million in Q4 2023 from $72 million in Q4 2022, representing a decline of 45.8%[31]. - Adjusted EBITDA for Q4 2023 was $172 million, down from $279 million in Q4 2022, with a full-year total of $984 million compared to $1,125 million in 2022[51]. Other Expenses - The company incurred one-time professional and other fees of $11 million related to a cybersecurity incident in Q4 2023[50]. - Interest expense for Q4 2023 was $29 million, significantly higher than $12 million in Q4 2022, with full-year interest expense at $87 million compared to $35 million in 2022[51]. - Depreciation and amortization for Q4 2023 was $68 million, up from $52 million in Q4 2022, with a full-year total of $248 million compared to $212 million in 2022[51]. - Restructuring and integration costs for Q4 2023 were $11 million, down from $96 million in Q4 2022[46]. - Acquisition intangible amortization for Q4 2023 was $43 million, up from $31 million in Q4 2022, with a full-year total of $151 million compared to $126 million in 2022[47]. - Impairment charges for certain intangible assets in Q4 2023 were $7 million, down from $34 million in Q4 2022, with net impairment charges for the full year at $5 million compared to $23 million in 2022[48]. - The company recorded an impairment of capitalized assets of $27 million in Q4 2023, with a net impact of $19 million after taxes[48]. - The amount attributable to noncontrolling interests in net income for Q4 2023 was $(1) million, compared to $4 million in Q4 2022[51].